87 related articles for article (PubMed ID: 3186719)
21. Chromosome analysis of a brain malignant lymphoma cell line.
Miyamoto K; Miyano K; Tabuchi K; Nishimoto A; Yoshida H; Yumoto T; Tanaka T
Acta Med Okayama; 1980 Mar; 34(2):117-22. PubMed ID: 6450513
[TBL] [Abstract][Full Text] [Related]
22. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
[TBL] [Abstract][Full Text] [Related]
23. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer.
Grenman SE; Van Dyke DL; Worsham MJ; del Rosario F; Roberts JA; McClatchey KD; Schwartz DR; Babu VR; Carey TE
Cancer Res; 1988 Apr; 48(7):1864-73. PubMed ID: 3349465
[TBL] [Abstract][Full Text] [Related]
24. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
Glasky MS; Reading CL
Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
Wikstrand CJ; Bigner SH; Bigner DD
Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
[TBL] [Abstract][Full Text] [Related]
26. A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma.
Kubonishi I; Sonobe H; Miyagi T; Iwahara Y; Ohyashiki JH; Ohyashiki K; Toyama K; Ohtsuki Y; Miyoshi I
Cancer Res; 1990 Dec; 50(23):7682-5. PubMed ID: 1979248
[TBL] [Abstract][Full Text] [Related]
27. Transformation of Bloom syndrome T-lymphocytes by cocultivation with a lethally irradiated human T-cell line carrying type C virus particles.
Shiraishi Y; Fujishita M; Miyoshi I; Kondo N; Orii T
Gan; 1983 Apr; 74(2):213-8. PubMed ID: 6305751
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
29. Thomsen-Friedenreich (T) antigen expression increases sensitivity of natural killer cell lysis of cancer cells.
Sotiriadis J; Shin SC; Yim D; Sieber D; Kim YB
Int J Cancer; 2004 Sep; 111(3):388-97. PubMed ID: 15221966
[TBL] [Abstract][Full Text] [Related]
30. Genetic characterization of single cell clones isolated from a radiation induced lymphoma in mice carrying the T (1:17) 190 chromosome translocation.
Włodarska I
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):443-59. PubMed ID: 2130807
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
Fizzotti M; Chen EY; Link MP; Carroll AJ; Foroni L; Rabbitts TH; Crist WM; Clark SS
Leukemia; 1994 Jul; 8(7):1124-30. PubMed ID: 8035604
[TBL] [Abstract][Full Text] [Related]
32. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
Jones B; Tite JP; Janeway CA
J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
[TBL] [Abstract][Full Text] [Related]
33. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
34. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH
J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229
[TBL] [Abstract][Full Text] [Related]
35. Microsatellite instability in B-cell lymphoma originating from Bloom syndrome.
Kaneko H; Inoue R; Yamada Y; Sukegawa K; Fukao T; Tashita H; Teramoto T; Kasahara K; Takami T; Kondo N
Int J Cancer; 1996 Dec; 69(6):480-3. PubMed ID: 8980251
[TBL] [Abstract][Full Text] [Related]
36. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
Maryanski JL; Boon T
Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
[TBL] [Abstract][Full Text] [Related]
37. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
38. Isodicentric 20q- in two cases of B-cell acute lymphocytic leukemia with the respective t(9;20)(p11;q11.2) and t(9;22)(q34;q11.2).
Li T; Xue Y; Zhang J; Chen S; Pan J; Wu Y; Wang Y; Shen J
Cancer Genet Cytogenet; 2008 Feb; 181(1):55-9. PubMed ID: 18262055
[TBL] [Abstract][Full Text] [Related]
39. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
40. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
